Prophylactic anticoagulation in cirrhotics: A paradox for prime time?

Gastroenterology

Volumn 143, Issue 5, 2012, Pages 1138-1141

  Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868033563     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.09.020     Document Type: Editorial

References (21)

1. C. Francoz, J. Belghiti, V. Vilgrain Splanchnic vein thrombosis in candidates for liver transplantation Usefulness of screening and anticoagulation Gut 54 2005 691 697
2. J.C. Garcia-Pagan, D. Valla Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol 51 2009 632 634
3. E.A. Tsochatzis, M. Senzolo, G. Germani Systematic review: portal vein thrombosis in cirrhosis Aliment Pharmacol Ther 31 2009 366 374
4. M.J. Englesbe, J. Kubus, W. Muhammad Portal vein thrombosis and survival in patients with cirrhosis Liver Transpl 16 2010 83 90
5. L. Amitrano, M.A. Guaradascione, V. Brancaccio Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis J Hepatol 40 2004 736 741
6. D. Zhang, J. Hao, N. Yang Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis J Gastroenterol Hepatol 25 2010 116 121
7. M.A. Zocco, E. Di S, R. De C Thrombotic risk factors in patients with liver cirrhosis Correlation with MELD scoring system and portal vein thrombosis development J Hepatol 51 2009 682 689
8. T. Lisman, R.J. Porte Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences Blood 116 2010 878 885
9. H.L. Janssen, J.R. Meinardi, F.P. Vieggaar Favor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis Blood 96 2000 2364
10. M. Primigani, I. Martinelli, P. Bucciarelli Risk factors for thrombophilia in extrahepatic portal vein obstruction Hepatology 41 2005 603
11. L.D. DeLeve, D.C. Valla, G. Garcia-Tsao Vascular disorders of the Liver AASLD practice Guideline 49 2009 1738 1754
12. B. Condat, F. Pessione, S. Hillaire Outcome of portal vein thrombosis in adults: risk and benefit of anticoagulation therapy Gastroenterology 120 2001 490 497
13. M. Senzolo, T.M. Sartori, V. Rossetto Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis Liver International 2012 919 927
14. L. Amitrano, M.A. Guardacione, A. Menchise Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis J Clin Gastroenterol 44 2010 448 451
15. E. Villa, C. Cammà, M. Marietta Enoxaprin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis Gastroenterology 143 2012 1253 1260
16. N.G. Sandler, C. Koh, A. Roque Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection Gastroenterology 141 2011 1220 1230
17. L.W. Lamps, C.M. Hunt, A. Green Alternations in colonic mucosal vessels in patients with cirrhosis and non-cirrhotic portal hypertension Human Pathol 28 1998 527 535
18. C. Ettelaie Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor KB Biochim Biophys Acta 1812 2011 1591 1600
19. I.R. Wanless, F. Wong, L.M. Blendis Hepatic and portal vein thrombosis in cirrhosis; possible role in development of parenchymal extinction and portal hypertension Hepatology 21 1995 1238 1247
20. I.R. Wanless, J.J. Liu, J. Butany Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis) Hepatology 21 1995 1232 1237
21. L.P. Bachmann, M. Sichau, M. Wichert Low-molecular weight heparin in patients with advanced cirrhosis Liver International 2010 75 82